Tag Innovation & tech transfer

Invitrogen, WARF sign license agreement for human embryonic stem cells

May 8, 2008

Invitrogen Corp. and the Wisconsin Alumni Research Foundation announced today (May 8) that they have signed a license for human embryonic stem cell (hESC) patents for the development of research tools.

WARF licenses influenza vaccine technology to FluGen

May 8, 2008

The Wisconsin Alumni Research Foundation and FluGen have signed license agreements for a technology that has the potential to significantly improve the way influenza vaccines are manufactured.

Roche NimbleGen CEO Stan Rose to speak on exit strategies for start-up companies

April 24, 2008

Stan Rose, president and CEO of Roche NimbleGen, a manufacturer of gene chips for pharmaceutical research, will speak about successful exit strategies for start-up companies on Monday, April 28 at 5 p.m. at the Fluno Center, 601 University Avenue. The event is free and open to the public as part of the Gilson Discovery Series hosted by the Wisconsin Alumni Research Foundation (WARF).

TomoTherapy’s Mackie to speak on faculty entrepreneurship

March 28, 2008

Thomas Rockwell Mackie, co-founder, chairman of the board and director of research at TomoTherapy, will speak on faculty entrepreneurship on Wednesday, April 2, beginning at 5 p.m. The event, part of the Gilson Discovery Series hosted by the Wisconsin Alumni Research Foundation, is free and open to the public.

Talk commemorates 75th anniversary of Warfarin saga

January 25, 2008

Seventy-five years ago this February, a Wisconsin dairy farmer brought some sweet clover hay to University of Wisconsin–Madison biochemist Karl Paul Link. The farmer suspected the clover had killed his cattle, which died from uncontrollable bleeding. From one farmer's misfortune, much good has come.

California company licenses WARF stem cell technology

January 9, 2008

BioTime, Inc. (OTCBB: BTIM) has signed a licensing agreement with the Wisconsin Alumni Research Foundation (WARF) for 173 patents and patent applications relating to human embryonic stem cell technology created by James Thomson at the University of Wisconsin–Madison.

WARF announces new hires and promotions

October 1, 2007

The Wisconsin Alumni Research Foundation (WARF) has announced promotions for Michael E. Falk and Emily Bauer, and the hires of a communications director, Janet L. Kelly, and two licensing professionals, Craig Heim for start-up companies, and Mark Stoveken for pharmaceutical licensing.

Basic research robust in face of more university patenting

September 10, 2007

A UW–Madison study of more than 1,800 U.S. life scientists found that, despite an explosion in academic patenting in recent years, most life science professors still do research the "old-fashioned" way: they win federal grants, publish results in scientific journals, and graduate Ph.D. students.

State seeds stem-cell company based on UW–Madison research

May 14, 2007

Governor Jim Doyle today (May 14) gave a $1 million boost to a University of Wisconsin–Madison spin-off company during a visit to the campus lab that gave birth to its technology.